E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma

Oral Oncol. 2022 Dec:135:106193. doi: 10.1016/j.oraloncology.2022.106193. Epub 2022 Oct 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Head and Neck Neoplasms* / drug therapy
  • Humans
  • Proteasome Endopeptidase Complex / metabolism
  • Signal Transduction
  • Squamous Cell Carcinoma of Head and Neck / drug therapy
  • Ubiquitin-Protein Ligases* / metabolism

Substances

  • Ubiquitin-Protein Ligases
  • Proteasome Endopeptidase Complex